SOLASTA Bio
Founded in 2020, SOLASTA Bio develops has developed the world's first technology platform for creating micro-peptide based Insect Control Agents (ICAs) that are nature-inspired rather than selected from a synthetic chemistry library. SOLASTA’s environmentally-friendly ICAs meet a global need for new and effective crop protection, while preserving the ecosystem by protecting beneficial pollinators such as bees.
Biopesticides
UK: SOLASTA Bio Continues Growth With Relocation to West of Scotland Science Park
The new premises house specialized facilities for R&D, including a dedicated insectary.
Industry News
UK: SOLASTA Bio Makes Trio of Senior Appointments to Fuel Growth
The three senior business and industry experts to support the company’s UK and US growth as it prepares for market entry.
Biopesticides
SOLASTA Bio Fast-Tracks to Market with Patent Win and EPA Green Light
The company is behind the world’s first technology platform for creating nature-inspired, small peptide-based insect control agents.
Biologicals
SOLASTA Bio Completes $14M Series A to Accelerate Nature-Inspired Crop Protection
Funding round to fuel development of its unique peptide-based, nature-inspired bioinsecticides – the first of their kind to be developed worldwide.
Biologicals
Green Bioinsecticides from SOLASTA Bio Move Closer to Market With Successful Field Trials
SOLASTA Bio’s unique micro-peptide Insect Control Agents, based on insect ‘neuropeptides’, demonstrated superb efficacy.
Latest News
AgriBusiness Global Report
AgriBusiness Global Report: Alex Mills of ADAMA Discusses ADAMA, BASF Partnership
Alex Mills, Head of Global Third Party Relations at...
ABG Update Feature
Agriculture Doesn’t Need Revolution, It Needs Reconciliation
Micropep CEO Georg Goeres argues agriculture needs reconciliation, not...
Biostimulants
Stimera Appoints Lon Kreger As CEO to Lead Next Chapter of Commercial Growth
Founder and President Reuben Rampersad continues to drive product...
Insecticides
Cyantraniliprole: Regulation, Generics, and the Staying Power of a Diamide
Cyantraniliprole faces tightening regulation yet shows resilience, as generics...